SLE Flashcards

1
Q

What is systemic lupus erythematosus (SLE)?

A

Systemic, inflammatory autoimmune connective tissue disease. Often takes a relapsing and remitting course.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the pathophysiology of SLE

A
  • Cell damage occurs resulting in apoptosis of cells
  • Apoptotic bodies form and these display internal components of cells e.g. from nuclear, cytoplasm and cell membrane
  • Usually, phagocytes clear these apoptotic bodies
  • If pt has susceptibility genes, their immune system is more likely to mount an immune response against these intracellular components exposed on apoptotic body. Furthermore, in pts with SLE there is decreased clearance of these apoptotic bodies
  • Immature APCs can bind to these apoptotic bodies and present the intracellular components -which were displayed on the apoptotic body - to immature T cells in lymph node
  • T cells differntiate into different mature T cells
  • TH2 cells activate plasma B cells causing them to produce autoantibodies to intracellular components-particularly the nuclear components of cells
  • Antibodies can then:
    • Circulate in body and bind to cells activating complement cascade
    • Bind to nuclear antigens and the antigen-antibody complex can deposit in other tissues in body
    • .. .both of the above cause inflammation and damage to organ
  • Type III hypersensitivity reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State some risk factors for SLE

A
  • Female sex
  • 15-45 years of age
  • Genetic factors/family history
  • African/Asian dec
  • Drugs
    • Drugs that trigger SLE like syndrome include: isoniazid, TNF inhibitors etc..
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Who does SLE typically present in?

A
  • Young to middle aged females
  • Asian/african ethnicity (if in US or Europe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State some symptoms of SLE

A
  • Fatigue
  • Weight loss
  • Arthralgia
  • Myalgia
  • Fever
  • Rash on face which is photosensitive
  • SOB
  • Mouth ulcers
  • Hair loss
  • Raynaud’s phenomenom
  • Abdo pain
  • Nausea, vomitting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State what you might find on clinical examination of somoeone with SLE

A
  • Lymphadenopathy
  • Splenomegaly
  • Hypertension
  • Signs of nephrosis e.g. oedema
  • Photosensitive malar rash
  • Discoid rash
  • Livedo reticularis
  • Mouth ulcers
  • Hair loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What mneumonic can you use to remember signs & symptoms of SLE?

A

SOAP BRAIN

  • Serositis: pleurisy, pericarditis
  • Oral ulcers (usually painless)
  • Arthritis (of small joints, non-erosive)
  • Photosensitivity and/or malar/discoid rash
  • Blood disorders (low WCC, lyphopenia, thrombocytopenia, haemolytic anaemia)
  • Renal involvement (glomerulonephritis, proteinuria)
  • Autoantibodies
  • Immunological tests e.g. low complements
  • Neurological disorder e.g. seizures, psychosis, anxiety and depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the most common cardiac manifestation of SLE?

A

Pericarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If you send a test for “antibodies to extractable nuclear antigens (anti-ENA antibodies)” to the lab it will check for antibodies to specific components in the cell nuclear. State the different types of anti-nuclear antibody and state what diseases they are present in

A
  • Anti-Smith: highly specific to SLE but not very sensitive
  • Anti-centromere: most associated with limited cutaneous systemic sclerosis
  • Anti-Ro and Anti-La: most associated with Sjogren’s
  • Anti-Scl-70: most associaed with systemic sclerosis
  • Anti-Jo-1: most associated with dermatomyositis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What investigations would you do if you suspect someone has SLE, include:

  • Bedside
  • Bloods
  • Imaging

*Where appropriate justify why you are doing each

A

Bedside

  • Urinalysis: detect renal disease

Bloods

  • FBC: anaemia & leukopenia are common
  • U&Es: check renal func
  • LFTs: check liver func
  • ANA autoantibodies: 85-95% of SLE pts are ANA positive. Highly sensitive
  • Anti-dsDNA autoantibodies: 70% of SLE pts are positive. Titre rises with disease severity. Highly specific.
  • Anti-ENA antibody test: anti-Ro and anti-La are common
  • Antiphospholipid antibodies: antiphospholipid syndrome can occur secondary to SLE in up to 40% SLE pts
  • Rheumatoid factor antibodies: 20% positive
  • ESR: often raised

Imaging

  • Any imaging appropriate for systemic symptoms e.g. CXR

Others:

  • Renal biopsy
  • Skin biopsy

ECG: if has cardiac symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to C3 & C4 as disease activity increases?

A

C3 and C4 fall with disease activity (due to consumption of complement proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CRP is usually raised in SLE; true or false?

A

FALSE; CRP is usually normal in SLE.

ESR & plasma viscosity are often raised. ESR generally used. If CRP is raised may indicate underlying infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Up to 40% of pts with SLE can develop antiphospholipid syndrome secondary to SLE; state two potential complications of anti-phospholipid syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What 2 criteria can you use to establish a diagnosis of SLE?

A

Use SLICC criteria or the ACR criteria

They both look at both symptoms & signs and immunological results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the management of SLE

A

Anti-inflammatory medication & immunsupression is mainstay of treatment. Treatment is usually titrated upwards to find minimal medication with least side effects to control symptoms:

Non-pharmacological

  • Sun protection
  • Health lifestyle (in view of CVD risk)

First line treatment Pharmacological

  • Hydroxychloroquine is treatment of choice!!
  • NSAIDs: may be used for arthritis pain in some patients
  • Steroids e.g. prednisolone: may be used for some patients where hydroxychloroquine and NSAIDS inadequete

Other pharmacological treatments

  • Immunosuppressants: methotrexate, mycophenolate mofetil, azathioprine, tacrolismus, leflunomide, ciclosporin
  • Biological therapies: rituximab, belimumab (monoclonal antibody against B-cell activating factor)
  • Cyclophosphamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State some potential complications of SLE

A
  • Cardiovascular disease: chronic inflammation in blood vessels leads to hyptension & coronary artery disease
  • Infection: part of disease process & secondary to immunosupressants
  • Anaemia of chronic disease
  • CKD: due to lupus neprhitis
  • Recurrent miscarriage: associated with pregnancy complications
  • Venous thromboembolism: 40% SLE get secondary anti-phospholipid syndrome
17
Q

Discuss the prognosis of SLE

A
  • 85% survival at 15yrs
  • Decreased life expectancy ,however this is improving with treatment- cardiovascular disease & infeciton iare leadign cause of death
18
Q

Explain the difference between a malar rash and a discoid rash that can be seen in SLE

A
  • Malar rash: erythema over malar eminences (typical butterfly rash)
  • Discoid rash: erythematous raised patches with keratotic scaling and follicular plugging
19
Q

Suggest why women may be more likely to develop autoimmune disease

A

Estrogens are though to be permissive for autoimmunity. Estradiol may prolong life of autoreactive B & T lymphocytes

20
Q

State some precipitating factors of exacerbation/acute SLE reaction

A
  • Sun exposure (UV-B)
  • Infections
  • Stress
  • Surgery
  • Pregnancy
21
Q

Summarise what autoantibodies are present in SLE

A
  • ANA (85-95%)
  • Anti-dsDNA (70%)
  • Anti-Ro and anti-La (common)
  • Anti-phospholipid antibodies (40%)

*NOTE: anti-dsDNA antibodies are highly specific to SLE meaning that pts without condition are very unlikely to have these antibodies

22
Q

What is lupus nephritis?

Discuss how it is managed

A
  • Inflammation of kidneys due to SLE; pts are monitored for it by doing regular urinalysis
  • Management:
    • Treat HTN
    • Initial therapy: glucocorticoids + either mycophenolate or cyclophosphamide
    • Subsequent therapy: mycophenolate (preferred) or azathioprine
23
Q

What is used to monitor disease in SLE?

A
  • Usually use ESR
  • Complement levels C3 & C4 are low in active disease
  • Anti-dsDNA titres can be used for monitoring in some patients
24
Q

State some causative drugs of drug-induced lupus

A

Most common causes

  • procainamide
  • hydralazine

Less common causes

  • isoniazid
  • minocycline
  • phenytoin
25
Q

What would be the results of following blood tests in drug induced lupus:

  • ANA
  • Anti-dsDNA
  • Anti-histone
A
  • ANA: positive in 100%
  • dsDNA: negative
  • anti-histone: positive in 80-90%
26
Q

What blood tests would you do if you suspect antiphospholipid syndrome?

**NOTE: would do others but idea is main ones with findings

A
  • Antibodies
    • anticardiolipin antibodies
    • anti-beta2 glycoprotein I (anti-beta2GPI) antibodies
    • lupus anticoagulant
  • FBC: thrombocytopenia
  • Coagulation: prolonged APTT
27
Q

Discuss the management of antiphospholipid syndrome

A

Management - based on EULAR guidelines

  • Primary thromboprophylaxis
    • low-dose aspirin
  • Secondary thromboprophylaxis
    • initial venous thromboembolic events: lifelong warfarin with a target INR of 2-3
    • recurrent venous thromboembolic events: lifelong warfarin; if occurred whilst taking warfarin then consider adding low-dose aspirin, increase target INR to 3-4
    • arterial thrombosis should be treated with lifelong warfarin with target INR 2-3